The Global Genotyping Market is estimated to be valued at approximately USD 2.42 billion in 2023 and is expected to grow at a robust CAGR of 14.59% over the forecast period 2024-2032. Request To ...

The future of the Saudi Arabia Diabetes Nutrition market in 2032 is promising, with a growing emphasis on personalized nutrition, functional foods, and holistic diabetes management. Staying ahead of ...

A study in the journal Nature explains how age reshapes the blood system. In both humans and mice, a few stem cells, or ...

ACMG Meeting, experts gathered to share breakthroughs in genetics. BioLogic Pharma Solutions stood out with new insights on ...

Regeneron is set to acquire 23andMe assets for $256 million to boost genetic drug discovery. The transaction is expected to close by third-quarter 2025.

Your DNA results are in — and they're 100% the property of a pharmaceutical manufacturer. It was announced today that 23andMe ...

Regeneron Commits to Comply with Company's Privacy Policy and All Applicable Law; No Changes to 23andMe's Privacy Policy or Consumer Genome Services Transaction Subject to Court Approval SAN FRANCISCO ...

Anjana Harve currently works at BJ's Wholesale Club Holdings, Inc., as Chief Information Officer & Executive VP from 2023, Tau Ventures LLC, as Advisor, and Wolters Kluwer NV, as Member-Supervisory ...

Acquisition is Strong Strategic Fit for BioMarin, Adding INZ-701, a Phase 3 Enzyme Replacement Therapy Being Developed for Treatment of ENPP1 DeficiencyFirst Pivotal Data Readout in Children ...

Medical records of hundreds of patients at a Sydney hospital's cancer genetics service have been reviewed following ...

Myriad Genetics (NASDAQ:MYGN) drives innovation in genetic testing within the NASDAQ biotechnology index, reflecting key ...